Cargando…
RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
The Mixed Lineage Leukemia (MLL) protein is an important epigenetic regulator required for the maintenance of gene activation during development. MLL chromosomal translocations produce novel fusion proteins that cause aggressive leukemias in humans. Individual MLL fusion proteins have distinct leuke...
Autores principales: | Wilkinson, Adam C., Ballabio, Erica, Geng, Huimin, North, Phillip, Tapia, Marta, Kerry, Jon, Biswas, Debabrata, Roeder, Robert G., Allis, C. David, Melnick, Ari, de Bruijn, Marella F.T.R., Milne, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607232/ https://www.ncbi.nlm.nih.gov/pubmed/23352661 http://dx.doi.org/10.1016/j.celrep.2012.12.016 |
Ejemplares similares
-
MiR‐27a downregulates 14‐3‐3θ, RUNX1, AF4, and MLL‐AF4, crucial drivers of blast transformation in t(4;11) leukemia cells
por: Fioretti, Tiziana, et al.
Publicado: (2022) -
MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation
por: Godfrey, Laura, et al.
Publicado: (2017) -
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
por: Crump, Nicholas T., et al.
Publicado: (2023) -
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
por: Kerry, Jon, et al.
Publicado: (2017) -
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
por: Castaño, Julio, et al.
Publicado: (2016)